Device Trial Radar · NCT01401088
Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma
Last checked: Nov 20, 2026Latest source record: Jan 3, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
30
Planned (sponsor's estimate)
Start
Jul 2011
Primary completion
Nov 2013
Study completion Dec 2013
Sponsor
- Lead sponsor
- AurolabAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 25, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of Aurolab Artificial Drainage Implant (AADI) on intraocular pressure reduction in patients with refractory glaucoma.
Conditions
- Glaucoma
Interventions
Artificial drainage implantDevice
Artificial drainage implant is used for intra ocular pressure reduction in patient with refractory glaucoma
Primary outcomes
What the sponsor says the trial is designed to measure.
- Intra Ocular Pressure (IOP)Time frame: One year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aravind Eye Hospital
Madurai, Tamil Nadu, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.